We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.35B
AUM Growth
+$120M
Cap. Flow
+$99.3M
Cap. Flow %
7.37%
Top 10 Hldgs %
81.83%
Holding
319
New
37
Increased
134
Reduced
124
Closed
14

Top Buys

Rank Stock Value
1
VIDI icon
Vident International Equity Strategy
VIDI
+$503M
2
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$26.2M
3
TIP icon
iShares TIPS Bond ETF
TIP
+$19.9M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$18.5M
5
DBP icon
Invesco DB Precious Metals Fund
DBP
+$13.7M

Top Sells

Rank Stock Value
1
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$281M
2
EEMV icon
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
+$180M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$21M
4
IAU icon
iShares Gold Trust
IAU
+$4.4M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$3.03M

Sector Composition

Rank Sector Weight
1 Healthcare 2.47%
2 Financials 2.22%
3 Energy 2.19%
4 Industrials 2.17%
5 Consumer Staples 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
126
Biogen
BIIB
$30B
$584K 0.04%
2,088
+9
+0.4% +$2.33K
LO
127
DELISTED
LORILLARD INC COM STK
LO
$584K 0.04%
11,539
+106
+0.9% +$5.28K
CMCSA icon
128
Comcast
CMCSA
$85B
$575K 0.04%
22,134
-1,926
-8% -$46.4K
VWO icon
129
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$570K 0.04%
+13,840
New +$571K
GSK icon
130
GSK
GSK
$104B
$567K 0.04%
8,510
+773
+10% +$50.1K
VOE icon
131
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$565K 0.04%
7,086
+1,219
+21% +$94.1K
ARMH
132
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$565K 0.04%
10,331
+2,632
+34% +$128K
RTN
133
DELISTED
Raytheon Company
RTN
$564K 0.04%
6,217
-417
-6% -$34.8K
CRM icon
134
Salesforce
CRM
$151B
$563K 0.04%
10,202
-453
-4% -$24.2K
BCE icon
135
BCE
BCE
$20.2B
$562K 0.04%
12,975
+394
+3% +$17.1K
SBUX icon
136
Starbucks
SBUX
$120B
$557K 0.04%
14,218
+2,570
+22% +$102K
CVS icon
137
CVS Health
CVS
$133B
$552K 0.04%
7,718
+343
+5% +$22K
CL icon
138
Colgate-Palmolive
CL
$73.1B
$546K 0.04%
8,368
-5,137
-38% -$329K
BUD icon
139
AB InBev
BUD
$170B
$538K 0.04%
5,056
+316
+7% +$32.3K
BCS icon
140
Barclays
BCS
$92.7B
$536K 0.04%
31,929
+4,116
+15% +$65.2K
BHP icon
141
BHP
BHP
$215B
$536K 0.04%
9,298
-50
-0.5% -$2.89K
TGT icon
142
Target
TGT
$65.6B
$532K 0.04%
8,408
+40
+0.5% +$2.56K
GOVT icon
143
iShares US Treasury Bond ETF
GOVT
$43.6B
$531K 0.04%
+21,838
New +$535K
TEVA icon
144
Teva Pharmaceuticals
TEVA
$40.8B
$528K 0.04%
13,185
-1,582
-11% -$62.3K
ADP icon
145
Automatic Data Processing
ADP
$106B
$525K 0.04%
7,406
-18
-0.2% -$1.21K
EL icon
146
Estee Lauder
EL
$30.4B
$516K 0.04%
6,849
+33
+0.5% +$2.39K
MET icon
147
MetLife
MET
$61.9B
$514K 0.04%
10,692
+1,478
+16% +$66.3K
GSG icon
148
iShares S&P GSCI Commodity-Indexed Trust
GSG
$998M
$502K 0.04%
+15,600
New +$499K
RDS.B
149
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$497K 0.04%
6,619
-2,145
-24% -$151K
PBR icon
150
Petrobras
PBR
$125B
$491K 0.04%
35,603
+13,302
+60% +$206K
4 5
6
7 8

Similar funds

DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return
1GA
1st Global Advisors Dallas, Texas $869M AUM 16.28% 1-Year Est. Return

Ronald Blue & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Ronald Blue & Co held 319 positions worth $1.35B, up 9.8% from $1.23B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Ronald Blue & Co deployed $99.3M of net new capital in Q4 2013, opening 37 new positions and adding to 134 existing holdings. Its largest new stake was Vident International Equity Strategy: 20,599,484 shares worth $511M.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, down from 2.5% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was iShares MSCI ACWI ex US ETF, an estimated $281M trimmed.

  • Ronald Blue & Co's largest Q4 2013 buy was Vident International Equity Strategy: 20,599,484 shares worth $511M.
  • Ronald Blue & Co added most to iShares Floating Rate Bond ETF in Q4 2013, an estimated $26.2M increase.
  • Ronald Blue & Co's biggest Q4 2013 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $281M.
  • Ronald Blue & Co fully exited ConocoPhillips in Q4 2013, selling an estimated $1.51M.
  • Ronald Blue & Co's ten largest holdings make up 82% of its $1.35B portfolio in Q4 2013.
  • Ronald Blue & Co opened 37 new positions and closed 14 in Q4 2013.
  • Ronald Blue & Co's portfolio value rose 9.8% quarter-over-quarter to $1.35B.

Based on Ronald Blue & Co's 13F filing for Q4 2013, filed 27 Jan 2014.